Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine

Current Drug Metabolism

Volumn 9, Issue 10, 2008, Pages 996-1009

  Wink, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gene regulation; Molecular target; Multi target activity; Pleiotropic activity; Protein structure; Secondary metabolite; Synergism

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKALOID; ANTHRAQUINONE DERIVATIVE; CATECHIN; CYTOCHROME P450; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; EPOXIDE; GLUCOSIDE; GLUCOSINOLATE; MULTIDRUG RESISTANCE PROTEIN 1; NATURAL PRODUCT; NUCLEIC ACID; PHENOL DERIVATIVE; POLYACETYLENE DERIVATIVE; PROCYANIDIN; SAPONIN; TANNIN; TERPENOID DERIVATIVE; PLANT EXTRACT;

BIOAVAILABILITY; CITRIC ACID CYCLE; DEFENSE MECHANISM; EUKARYOTIC CELL; FRAMESHIFT MUTATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HERBIVORE; MEDICINAL PLANT; MEMBRANE PERMEABILITY; METABOLITE; NONHUMAN; PHYTOCHEMISTRY; PHYTOTHERAPY; PLANT ANIMAL INTERACTION; PLANT METABOLISM; PLANT MICROORGANISM INTERACTION; PLEIOTROPY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING; TRANSCRIPTION REGULATION; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM;

CELL MEMBRANE; DRUG SYNERGISM; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 62749198712     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008786927794     Document Type: Review

References (59)

1. Reynolds, J.E. Martindale: The Extra Pharmacopoeia, 3rd ed.; Pharmaceutical Press: London, 1993.
2. Mutschler, E.; Geisslinger, G.; Kroemer, H.K.; Ruth, P.; Schäfer-Korting, M. Mutschler Arzneimittelwirkungen. 9th ed.; Wissensch. Verlagsgesellschaft: Stuttgart, 2008.
3. Wyk van, B.E.; Wink, M. Medicinal Plants of the World, BRIZA: Pretoria, 2004.
4. Hänsel, R.; Sticher, O. Pharmacognosie - Phytopharmazie, 8th ed.; Springer: Heidelberg, 2007.
5. Hou, J.P.; Jin, Y. The healing power of Chinese herbs and medicinal recipes. Haworth Press: New York, 2005.
6. E/S/C/O/P Monographs. The Scientific Foundation for Herbal Medicinal Products. 2nd ed.; Thieme: Stuttgart, 2003.
7. Wink, M. In The Alkaloids; Cordell, G., Ed.; Academic press: San Diego, 2007; Vol. 64, pp. 1-48.
8. Wink, M. In Modern Alkaloids; Fattorusso, E.; Taglialatcla-Scafati, O. Ed.; Wiley-VCH: Weinheim, 2008; pp. 3-24.
9. Wink, M. Die Verwendung pflanzlicher Vielstoffgemische in der Phytotherapie: Eine evolutionäre Sichtweise. Phytotherapie, 2005, 5, 33-39.
10. Wink, M. (2005) Wie funktionieren Phytopharmaka? Wirkmechanismen der Vielstoffgemische. Z. Phytother., 2005, 26, 271-274.
11. Dewick, P.M. Medicinal Natural Products. A biosynthetic approach, 2nd ed.: Wiley: New York, 2002.
12. Dey, P.M.; Harborne, J.B. Plant Biochemistry, Academic Press: San Diego, 1997.
13. Harborne, J.B. Introduction to Ecological Biochemistry, 4th ed.; Academic Press: London, 1993.
14. Seigler, D.S. Plant Secondary Metabolism, Kluwer: Boston, 1998.
15. Roberts, M.F.; Wink, M. Alkaloids:- Biochemistry, Ecological Functions and Medical Applications, Plenum: New York, 1998.
16. Brown, K.; Trigo, J.R. In The Alkaloids; Cordell, G.A., Ed.; Academic Press: San Diego, 1995, Vol. 47, pp. 227-354.
17. Wink, M. In The Alkaloids; Cordell, G.A., Ed.; Academic Press: San Diego, 1993, Vol. 43, pp. 1-118.
18. Wink, M. In Bioactive Natural Products; Atta-Ur-Rahman, Ed.; Elsevier Science B. V.: Amsterdam, 2000, pp. 1-127.
19. Wink, M. Biochemistry of Plant Secondary Metabolism, Sheffield Academic Press: Sheffield, 1999, Vol. 2.
20. Wink, M. Function of Plant Secondary Metabolites and their Exploitation in Biotechnology, Sheffield Academic Press: Sheffield, 1999, Vol. 3.
21. Rosenthal, G.A. Plant Nonprotein Amino and Imino Acids, Academic Press: New York, 1982.
22. Minto, R.E.; Blacklock, B.J. Biosynthesis and function of polyacetylenes and allied natural products. Prog. Lipid Res., 2008, 47, 233-306.
23. Wink, M. The plant vacuole: A multifunctional compartment. J. Exp. Bot., 1993, 44, 231-46.
24. Verpoorte, R.; Alfermann, A.W.; Johnson, T.S. Applications of Plant Metabolic Engineering, Springer: Heidelberg, 2007.
25. Zenk, M.H.; Juenger, M. Evolution and current status of the phytochemistry of nitrogenous compounds. Phytochemistry, 2007, 68, 2757-2772.
26. Rosenthal, G.A.; Berenbaum, M.R. Herbivores: Their Interactions with Secondary Plant Metabolites, Academic Press: San Diego, Vol. 1, 1991.
27. Rosenthal, G.A.; Berenbaum, M.R. Herbivores: Their Interactions with Secondary Plant Metabolites, Academic Press: San Diego, Vol. 2, 1992.
28. Wink, M. Plant breeding: Importance of plant secondary metabolites for protection against pathogens and herbivores. Theor. Appl. Genet., 1988, 75, 225-233.
29. Wink, M. In Insect-Plant Interactions; Bernays, E.A., Ed.; CRC Press: Boca Raton, 1992, Vol. 4, pp. 133-69.
30. Wink, M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry, 2003, 64, 3-19.
31. Hartmann, T. From waste products to ecochemicals: Fifty years research of plant secondary metabolism. Phytochemistry, 2007, 68, 2831-2846.
32. Wink, M. Plant secondary metabolism: Diversity, function and its evolution. Nat. Prod. Commun., 2008, 3, 1205-1216.
33. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Molecular Biology of the Cell, 5th ed.; Garland Science: New York, 2008.
34. Wink, M.; van Wyk, B.-E. Mind-altering and Poisonous Plants of the World. BRIZA: Pretoria, 2008.
35. Schmeller, T.; Wink, M. In Alkaloids: Biochemistry, Ecology and Medicinal Applications; Roberts, M.F.; Wink, M., Ed.; Plenum: New York, 1998, pp. 435-58.
36. Jastorff, B.; Störmann, R.; Wölcke, U. Struktur-Wirkungsdenken in der Chemie- eine Chance für mehr Nachhaltigkeit. Universiätsverlag Aschenbeck & Isensee: Bremen, 2003.
37. Wink, M.; Schimmer, O. In Function of Plant Secondary Metabolites and their Exploitation in Biotechnology; Wink, M., Ed.; Sheffield Academic Press: Sheffield, 1999, Vol. 3, pp.17-133.
38. Scott, B.R.; Pathak, M.A.; Mohn, G.R. Molecular and genetic basis of furocoumarin reactions. Mutat. Res., 1976, 39 29-74.
39. Wailes, S.A.S. DNA damage by hydroquinone und duroquinone. Mutat. Res., 1990, 234, 409-415.
40. Schmeller, T.; Latz-Brüning, B; Wink, M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry, 1997, 44, 257-66.
41. Saito, K.; Nagao, T.; Takatsuki, S.; Koyama, K.; Natori, S. The sesquiterpenoid carcinogen of bracken fern and some analogues, from the Pteridaceae. Phytochemistry, 1990, 29, 1475-79.
42. Puri, E.C.; Müller, D. Mutagenic properties and carcinogenicity of aristolochic acid. Mutat. Res., 1995, 147 133-34.
43. Pfyffer, G.E.; Pfyffer, B.U.; Towers, G.H.N. Monoaddition of dictamnine to synthetic double-stranded polydeoxyribonucleotides inUVA and the effect of photomodified DNA on template activity. Photochem. Photobiol., 1982, 35 793-97.
44. Paulini, H.; Schimmer, O. Mutagenicity testing of rutacridone epoxide and rutacridone alkaloids in Ruta graveolens using Salmonella/microsome assay. Mutagenesis, 1989, 4, 45-50.
45. Pfau, W.; Schmeiser, H.H.; Wiessler, M. (1990) Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis, 1990, 11, 313-19.
46. Musk, S.R.R.; Smith, T.K.; Johnson, I.T. On the cytotoxicity and genotoxicity of allyl and phenethyl isithiocyanates and parent glucosinolates, sinigrin and gluconasturtin. Mutat. Res., 1995, 348, 19-23.
47. Nandi, R.; Maiti, M. Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem. Pharmacol., 1985, 34, 321-24.
48. Mengs, U. Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol., 1988, 61, 504-505.
49. Mattocks, A.R. Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press: London, 1986.
50. Ivie, G.W.; MacGregor, J.T.; Hammock, B.D. Mutagenicity of psoralen epoxides. Mutat. Res., 1980, 79, 73-77.
51. Pakalapati, G.; Wink, M.; Li, L; Gretz, N.; Koch, E. Influence of Red Clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats. Phytomedicine (accepted).
52. Rosenkranz, V.; Wink, M. Induction of apoptosis by alkaloids in human promyelotic HL-60 cells. Z. Naturforschung- J. Bioscience, 2007, 62c, 458-466, 2007.
53. Guofeng, Y.; Morris, M.E. Drug transporters- Molecular characterization and role in drug disposition, Wiley-Interscience: Hoboken, New Jersey, 2007.
54. Ma, Y.; Wink, M. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependant multidrug resistance in tumor cells. Phytomedicine, 2008, 15, 754-758.
55. Hebestreit, P.; Melzig, M. Cytotoxic activity of the seeds from Agrostemma githago var. githago. Planta Med., 2003, 69, 921-925
56. Bachran, C.; Sutherland, M.; Heisler, I.; Hebestreit, P.; Melzig, M.F.; Fuchs, H. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure. Exp. Biol. Med., 2006, 231, 412-420.
57. Hanson, B.A. Understanding medicinal plants. Their chemistry and therapeutic action. Haworth Herbal Press: New York, 2005.
58. Efferth, T.; Fu Y., Zu, Y.; Schwarz, G.; Newman, D.; Wink, M. Molecular target-guided tumor therapy with natural products derived from Traditional Chinese Medicine. Curr. Med. Chem., 2007, 14, 2024-2032.
59. Möller, M.; Herzer, K.; Wenger, T.; Herr, I.; Wink, M. The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukaemia cells. Oncol. Rep., 2007, 14, 737-744.